Development of technology for a combination anthrax-plague live oral vaccine

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

Develop and characterize in two animals the immunogenicity and protective efficacy of a single, combined multivalent live, oral vaccine for protection against anthrax and plague.